King Mohammed VI chaired, this Monday, July 5, 2021 at the Royal Palace in Fez, the launching and signing ceremony of conventions relating to the project of manufacturing and syringing in Morocco the anti-Covid19 vaccine and other vaccines.
This structuring project is part of the royal desire to provide Morocco with complete and integrated industrial and biotechnological capacities, dedicated to the manufacture of vaccines at the national level.
Its purpose is the production in our country of the anti-Covid vaccine, as well as other key vaccines, so as to promote Morocco’s self-sufficiency and make it a leading biotechnology platform on the scale of the continent of Africa and the world in the field of the “fill & finish” industry.
The result of a public-private partnership, the project aims to start in the short term with a production capacity of 5 million doses of anti-Covid19 vaccine per month, before gradually increasing this capacity in the medium term. It will mobilize a global investment of around $ 500 million.
With the launch of this large-scale partnership, which follows on from the telephone interview of August 31, 2020 between King Mohammed VI and Chinese President Xi Jinping, Morocco is taking a further step towards effective management and proactive approach to the pandemic crisis and its consequences.
While strengthening the health sovereignty of the kingdom, the project presented to the sovereign consecrates Morocco’s international influence and strengthens its vocation as a provider of health security within its regional and continental environment, in the face of health risks, external dependencies and contingencies policies.
At the start of this ceremony, and after an introductory word from Khalid Ait Taleb, Minister of Health, Mr. Samir Machour, international expert in industrial biotechnology and currently vice-president of Samsung Biologics, presented the syringe and manufacture in Morocco of the anti-Covid vaccine and other vaccines.
Subsequently, the CEO of the Sinopharm group, Mr. Liu Jingzhen, intervened at a distance from China. The CEO of the Recipharm Company, Mr. Marc Funk, also presented the project to establish vaccine manufacturing capacities in Morocco.
On this occasion, and after presentation of the objectives and components of the project, three important agreements were signed before the king, namely:
1-The Memorandum relating to cooperation for the anti-Covid19 vaccine between the Moroccan State and the National Pharmaceutical Group of China (SINOPHARM), signed by the Minister of Health, Mr. Khalid Ait Taleb, and the Chairman of the Sinopharm Group, Mr. Liu Jingzhen.
2-The Memorandum of Understanding concerning the establishment of vaccine manufacturing capacities in Morocco between the Moroccan State and the company Recipharm, signed by the Minister of the Economy, Finance and the Reform of the Administration, and Chairman of the Board of Directors of the Mohammed VI Investment Fund, Mr. Mohamed Benchaâboune, the CEO of the Recipharm Company, Mr. Marc Funk, and the representative of the consortium of Moroccan banks, Mr. Othmane Benjelloun.
3-The contract for the provision to the Moroccan State of the aseptic filling facilities of the Moroccan Therapeutic Company (Sothema) for the manufacture of the anti-Covid19 vaccine owned by the company Sinopharm between the Moroccan State and the company Sothema, signed by the Minister of Health, Mr. Khalid Ait Taleb, and the Chief Executive Officer of Sothema, Ms. Lamia Tazi.
In addition to the signatories, also attended this ceremony, the Head of Government, Mr. Saad Eddine El Otmani, the King’s advisor, Mr. Fouad Ali El Himma, the Minister of Foreign Affairs, African Cooperation and Moroccans residing abroad, Mr. Nasser Bourita, the CEO of Attijariwafa-Bank, Mr. Mohamed Kettani and the CEO of the Banque Populaire, Mr. Mohamed Karim Mounir.